PROCEPT BioRobotics stock gained 0.82 percent on October 2
Published on 10/04/2026 at 18:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
PROCEPT BioRobotics stock (ISIN US74276L1052) closed at USD 17.16 on Nasdaq on October 2, 2026, gaining 0.82 percent from the prior close. The same-day filing expanded the board from nine to ten members and appointed Dr. Michael Mack as an independent Class II director, according to StockTitan.
Board expands to ten directors
The appointment took effect on October 2, 2026, and Mack's initial term runs through the 2029 annual meeting. The filing identifies him as a cardiac surgeon and an independent director under Nasdaq listing requirements.
Mack has more than 1,100 peer-reviewed publications and serves as chairman of the Baylor Scott & White Research Institute, according to StockTitan. The change adds clinical and governance experience to a company focused on robotic urology systems.
Q2 growth meets a loss
PROCEPT reported USD 94.5 million of revenue in Q2 2026, a 19.3 percent increase from the same quarter of 2025. Diluted EPS was negative USD 0.47, compared with negative USD 0.35 in the prior-year quarter, according to MarketBeat.
The revenue result exceeded the cited consensus estimate of USD 92.77 million, while the loss was USD 0.01 wider than the USD 0.46 consensus loss. PROCEPT also reaffirmed fiscal 2026 sales guidance of USD 390 million to USD 410 million, representing growth of 27 percent to 33 percent, according to Investing.com.
Consensus target stays above price
The analyst consensus remains Hold, based on 15 analysts: nine Hold ratings, three Buy ratings, one Strong Buy and two Sell ratings. The average 12-month price target is USD 25.09, with a high of USD 51.00 and a low of USD 19.00, according to MarketBeat.
At USD 17.16, the average target lies 46.2 percent above the October 2 closing price. That gap sits beside a still-negative quarterly result, making revenue growth and the path toward profitability the central operating measures for the stock.
October 2 close and yearly range
PROCEPT BioRobotics stock closed at USD 17.16 on Nasdaq on October 2, 2026, with volume of 1,240,738 shares and a market capitalization of USD 976.7 million. The 52-week range was USD 16.66 to USD 38.11.
PROCEPT BioRobotics stock facts
- Company: PROCEPT BioRobotics Corporation
- ISIN: US74276L1052
- Ticker: PRCT
- Trading venue: Nasdaq
- Price (as of October 2, 2026, 4:00 p.m. ET): Closing price (October 2, 2026) USD 17.16
- Market capitalization: USD 976.7 million (as of October 2, 2026)
- 52-week range: USD 16.66-38.11 (as of October 2, 2026)
- Sector / Industry: Healthcare / Medical Devices
